J
Javier R. Lama
Researcher at Asociación Civil Impacta Salud y Educación
Publications - 141
Citations - 11117
Javier R. Lama is an academic researcher from Asociación Civil Impacta Salud y Educación. The author has contributed to research in topics: Men who have sex with men & Population. The author has an hindex of 31, co-authored 127 publications receiving 9633 citations.
Papers
More filters
Journal ArticleDOI
QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial.
Kelly E. Dooley,Susan L. Rosenkranz,Francesca Conradie,Laura Moran,Richard Hafner,Florian von Groote-Bidlingmaier,Javier R. Lama,Justin Shenje,Justin Shenje,Jorge M. de los Rios,Kyla Comins,Joel Morganroth,Andreas H. Diacon,Yoninah S Cramer,Kathleen Donahue,Gary Maartens,Oladapo Alli,Joan Gottesman,Maria Guevara,Chris Hikuam,Laura Hovind,Mats O. Karlsson,Jennifer McClaren,Helen McIlleron,William Murtaugh,Barbara Rolls,Akbar Shahkolahi,Lynnett Stone,Gerald Tegha,Jacob Tenai,Caryn Upton,Chanelle Wimbish +31 more
TL;DR: The ACTG A5343 trial as discussed by the authors showed that combining bedaquiline and delamanid has a modest, no more than additive, effect on the QTc interval, and initial microbiology data are encouraging.
Journal ArticleDOI
Leveraging social capital: multilevel stigma, associated HIV vulnerabilities, and social resilience strategies among transgender women in Lima, Peru.
Amaya Perez-Brumer,Sari L. Reisner,Sarah McLean,Alfonso Silva-Santisteban,Leyla Huerta,Kenneth H. Mayer,Jorge Sanchez,Jesse L. Clark,Matthew J. Mimiaga,Javier R. Lama +9 more
TL;DR: This study applies the understanding of social capital as a social determinant of health and examines its relationship to HIV vulnerabilities to TW in Peru.
Journal ArticleDOI
25-Hydroxyvitamin D Insufficiency and Deficiency is Associated with HIV Disease Progression and Virological Failure Post-Antiretroviral Therapy Initiation in Diverse Multinational Settings
Fiona Havers,Laura M. Smeaton,Nikhil Gupte,Nikhil Gupte,Barbara Detrick,Robert C. Bollinger,Robert C. Bollinger,Robert C. Bollinger,James Hakim,Nagalingeswaran Kumarasamy,Adriana Andrade,Parul Christian,Javier R. Lama,Thomas B. Campbell,Amita Gupta,Amita Gupta,Amita Gupta,Nwcs Study Teams +17 more
TL;DR: Low 25(OH)D is common in diverse HIV-infected populations and is an independent risk factor for clinical and virologic failure, and studies examining the potential benefit of vitamin D supplementation among HIV patients initiating cART are warranted.
Journal ArticleDOI
Sampling Methodologies for Epidemiologic Surveillance of Men Who Have Sex with Men and Transgender Women in Latin America: An Empiric Comparison of Convenience Sampling, Time Space Sampling, and Respondent Driven Sampling
Jesse L. Clark,Kelika A. Konda,Alfonso Silva-Santisteban,Jesus Peinado,Javier R. Lama,L. Kusunoki,Amaya Perez-Brumer,M. Pun,Robinson Cabello,Jose Sebastian,Luis Suarez-Ognio,Jorge Sanchez +11 more
TL;DR: Comparing CS, time space sampling (TSS), and respondent driven sampling (RDS) for recruitment of men who have sex with men (MSM) and transgender women (TW) in Lima, Peru found alternatives to convenience sampling (CS) are needed for HIV/STI surveillance of most-at-risk populations in Latin America.
Journal ArticleDOI
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel.
Ross D. Cranston,Javier R. Lama,Barbra A. Richardson,Barbra A. Richardson,Alex Carballo-Diéguez,Ratiya Pamela Kunjara Na Ayudhya,Karen Liu,Karen Patterson,Cheng-Shiun Leu,Beth Galaska,Cindy Jacobson,Urvi M. Parikh,Mark A. Marzinke,Craig W. Hendrix,Sherri Johnson,Jeanna M. Piper,Cynthia I. Grossman,Ken S. Ho,Jonathan Lucas,Jim Pickett,Linda-Gail Bekker,Suwat Chariyalertsak,Anupong Chitwarakorn,Pedro Gonzales,Timothy H. Holtz,Albert Y. Liu,Kenneth H. Mayer,Carmen D. Zorrilla,Jill L. Schwartz,James F. Rooney,Ian McGowan +30 more
TL;DR: Rectal application of RG TFV gel was safe in MSM and TGW andherence and product use likelihood were similar for the intermittent gel and daily oral FTC/TDF regimens, but lower for the daily gel regimen.